Factors governing cutaneous vasoconstriction during hemorrhage.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001011:Aorta; D001783:Blood Flow Velocity; D001794:Blood Pressure; D004285:Dogs; D006470:Hemorrhage / Q000503:physiopathology*; D007668:Kidney / Q000503:physiopathology; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D012867:Skin / Q000098:blood supply*; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects
D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D000804:Angiotensin II